Related Experiment Video

Updated: May 13, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Natural compounds with cell growth inhibitory activity in human tumor cell lines

Cristiane M Cazal, Kantima Choosang, Vanessa Gisele P Severino

  • 1CEQUIMED-UP/CEQOFFUP - Centro de Estudos de Quimica, Medicinal, Faculdade de Farmacia, Universidade do Porto, Porto, Portugal, Departamento de Ciencias Quimicas, Laboratorio de Quimica Organica e Farmaceutica, Faculdade de Farmacia, Universidade do Porto, Porto, Portugal. madalena@ff.up.pt.

Anti-Cancer Agents in Medicinal Chemistry
|February 27, 2013
PubMed

Insights

This study evaluated 26 compounds for anti-cancer activity against human tumor cell lines. Three potent compounds, including 3-hydroxyflavone, demonstrated significant inhibition of breast, lung, and melanoma cancer cell growth.

Area of Science:

  • Natural Products Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Natural products, including coumarins, flavonoids, and alkaloids, are a rich source of potential anti-cancer agents.
  • Identifying novel compounds with potent anti-tumor activity is crucial for cancer therapy development.

Purpose of the Study:

  • To evaluate the in vitro anti-proliferative effects of 26 natural compounds against human cancer cell lines.
  • To identify specific compounds with significant inhibitory activity against breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460), and melanoma (A375-C5).
  • To explore the structure-activity relationships of the most potent compounds.

Main Methods:

  • Cytotoxicity assays were performed on MCF-7, NCI-H460, and A375-C5 cell lines.
  • Twenty-six diverse compounds, including coumarins, flavonoids, and alkaloids, were screened.
  • Potent compounds were identified based on their ability to inhibit tumor cell growth.

Main Results:

  • Three compounds, specifically 3-hydroxyflavone (6), 2'-hydroxy-3,4,4',5,6'-pentamethoxychalcone (11), and Siderin (20), exhibited potent inhibition across all tested human tumor cell lines.
  • These three compounds demonstrated significant anti-proliferative activity against breast, lung, and melanoma cancer cells.
  • The study provides preliminary structure-activity relationship insights for these potent anti-cancer natural products.

Conclusions:

  • Natural compounds, particularly flavonoids like 3-hydroxyflavone and Siderin, show significant promise as anti-cancer agents.
  • The identified potent compounds warrant further investigation for their therapeutic potential in treating breast, lung, and melanoma cancers.
  • Structure-activity relationship analysis can guide the development of more effective anti-cancer drug candidates from natural sources.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...